August 14, 2019 – “If providers are unable to get the full picture of a patient’s condition, it can often have tragic consequences,” Blumenauer said in a statement to Modern Healthcare. “The AMA’s recognition of this has provided momentum in Congress to make meaningful reforms that will ensure physicians have all of the necessary information to provide care to all patients regardless of the possibility that they are suffering from a substance-use disorder.” The bill was close to making it into opioid package, but the AMA expressly opposed it and the effort died. Then in June of this year, the AMA’s House of Delegates changed its policy stance and voted to support alignment of 42 CFR Part 2 with HIPAA “for the purposes of treatment, payment and health care operations,” as long as appropriate safeguards are maintained. The legislation has both ardent supporters and detractors. Supporters say that given the ravages of the opioid epidemic, clinicians need to know whether they are prescribing opioids to people who have struggled with addiction. “There is no argument that the restrictions of 42 CFR Part 2 has cost lives,” Blumenauer said.
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…